PTC Completes Acquisition Of St-920 Fabry Disease Gene Therapy
Sept 22 (Reuters) - PTC Therapeutics, Inc. PTCT.O:
PTC COMPLETES ACQUISITION OF ST-920 FABRY DISEASE GENE THERAPY
PTC THERAPEUTICS, - EXPECTS ST-920 BLA SUBMISSION TO FDA COMPLETED IN Q4 2026
Further company coverage: PTCT.O